FDA
label_change
· 2022-03-18
FDA Approved: WINLEVI — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved a supplemental application for WINLEVI (clascoterone) from Sun Pharmaceutical Industries, updating the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for WINLEVI (CLASCOTERONE)